A novel quantitative PCR detects Babesia infection in patients not identified by currently available non-nucleic acid amplification tests by unknown
RESEARC ARTICLE Open Access
A novel quantitative PCR detects Babesia
infection in patients not identified by
currently available non-nucleic acid
amplification tests
Lavoisier Akoolo1†, Samantha Schlachter1†, Rasel Khan1, Laura Alter1, Albert D. Rojtman2, Kristine Gedroic3,
Purnima Bhanot1 and Nikhat Parveen1*
Abstract
Background: Ticks transmit Babesia microti, the causative agents of babesiosis in North America and Europe. Babesiosis
is now endemic in Northeastern USA and affects people of all ages. Babesia species infect erythrocytes and can be
transmitted through blood transfusion. Whole blood and blood products, which are not tested for Babesia, can cause
transfusion-transmitted babesiosis (TTB) resulting in severe consequences in the immuno-compromised patients. The
purpose of this study was epidemiological evaluation of babesiosis in a tick-infested state.
Results: We examined blood samples from 192 patients who visited clinics during the active tick-borne diseases season,
using a newly developed qPCR assay that uses the specific molecular beacon probe. Due to the absence of clear
symptomology, clinical laboratories did not test 131 samples by IFA, FISH or microscopic examination of Giemsa-stained
blood smears. Babesia infection was detected in all age groups by FISH and microscopy; notably patients >40 years of
age represented 64% of tested samples and 13% were younger patients. We tested all samples using qPCR and found
that 38% were positive for Babesia. Of 28 samples that were positive by FISH, 27 (96%) were also positive by qPCR
indicating high congruency between nucleic acid based tests. Interestingly, of 78 asymptomatic samples not tested by
FISH, 22 were positive by our qPCR. Direct detection of Babesia relies upon microscopic examination of patient blood
smears, which is labor intensive, difficult to scale up, requires specific expertise and is hence, often not performed. In fact,
a clinical laboratory examined only 23 of 86 blood samples obtained from two different counties by microscopy. By
considering individuals positive for Babesia infection when results from currently available microscopy, FISH or serological
tests were positive, we found that our qPCR is highly sensitive (96.2%) and showed a specificity of 70.5% for Babesia.
Conclusion: Robust qPCR using specific probes can be highly useful for efficient and appropriate diagnosis of babesiosis
in patients in conjunction with conventional diagnostics, or as a stand-alone test, especially for donated blood screening.
The use of a nucleic acid amplification test based screening of blood and blood products could prevent TTB.
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Background
Tick-borne diseases have become increasingly prominent
among populations in North American continent and
Europe. In fact, Lyme disease caused by Borrelia burgdor-
feri sensu lato infection is the most prevalent arthropod-
borne disease in the United States and Europe; however,
ticks in both continents are increasingly infected by mul-
tiple pathogens [1–6]. A recent report suggests that trans-
mission of Babesia species, is promoted by coinfections of
reservoir host, the white-footed mouse Peromyscus leuco-
pus, with B. burgdorferi [7].
Babesiosis case was first reported in 1893 [8]. B.
microti transmitted by Ixodes scapularis ticks is the main
cause of human babesiosis in the United States although
some cases of B. duncani infection have been reported
from the Western, coastal states [9]. Babesiosis was first
detected in New Jersey in 1969 [10] and has now spread
to wider geographic regions, such that in 2011, CDC de-
clared it as a notifiable disease. According to the CDC,
B. microti infection affects the Northeastern United
States - Connecticut, Massachusetts, New Jersey, New
York, and Rhode Island along with the Midwestern State
of Wisconsin and Minnesota with1636 out of 1744 cases.
Together they represented 94% of babesiosis cases in the
USA in 2014.
Babesia species infects red blood cells and disease can
also be transmitted through transfusion of blood affecting
already ill recipients. Whole blood and blood products,
which are not tested for the presence of Babesia, can cause
blood transfusion transmitted babesiosis (TTB); resulting
in severe consequences in the immuno-compromised
patient populations. Due to increasing reported incidence
of TTB [11], FDA has recently recommended that blood
donors should be screened for Babesia infection (http://
www.fda.gov/downloads/advisorycommittees/committees
meetingmaterials/bloodvaccinesandotherbiologics/blood
productsadvisorycommittee/ucm446274.pdf ). From a
clinical perspective, infection of humans by Babesia species
shows wide-ranging manifestation from asymptomatic to
mild flu-like symptoms in immunocompetent people to
acute or sometimes fatal disease in splenectomized and im-
munocompromised individuals or elderly people [11–20].
Patients are often tested for babesiosis only after they
manifest hemolytic anemia. Babesia species can also trans-
mit through transplacental route [21–23] and can cause
jaundice, anemia and neutropenia in infants.
Microscopic examination of Giemsa-stained blood smears
provides compelling evidence of infection by Babesia spe-
cies. This method is labor intensive and time-consuming
and requires a specific expertise for making correct diagno-
sis because pleomorphic and non-synchronous trophozoites
and ring forms can sometimes make it difficult to identify
Babesia infection [15]. Recent studies have indicated that
Nucleic Acid Testing (NAT) has more promise for diagnosis
of babesiosis including among blood donors [24, 25]. Since
it is challenging to detect parasitized erythrocytes in early or
chronic stages of infection when parasitemia is low or inter-
mittent, serological assays are often found to be more sensi-
tive in detecting infection with Babesia species [26–32];
however, these tests cannot detect acute disease before the
adaptive immune response is triggered and are also unable
to distinguish active disease from the past infections, thus
creating a major diagnostic problem particularly in the
endemic regions [33, 34]. In this study, we used our
novel qPCR test based upon molecular beacon probe
with patient samples to evaluate its potential for early
detection of babesiosis to prevent further transmission
of this protozoan. Thus, we present here detection of
Babesia presence in 192 patients from New Jersey by our
qPCR assay and compared it with IFA, FISH and micros-
copy results whenever available.
Methods
Samples collection and experimental ethics
Patients presenting different clinical symptoms arrived at
Gedroic Center in Morris County, and Meridian hospitals
in Ocean and Monmouth Counties of New Jersey and
were recommended to get testing for tick borne diseases,
either for initial evaluation or follow-up care. At the
Gedroic Center, a history of tick bite, and patients present-
ing with high fever (>102°F) eight weeks after noticing a
tick-bite were suspected of suffering from babesiosis. Fur-
thermore, if a patient reported a history of erythema
migrans indicating tick-borne infection, or exhibited two
of the three symptoms, night sweats, shortness of breath
and frontal headaches, a high index of Babesia infection
was considered and samples were sent to IGeneX for test-
ing. Blood samples were collected from 106 patients who
came to the Gedroic Center that also included patients
who were considered asymptomatic for babesiosis.
Patient identification criteria for testing at Meridian
hospitals/Jersey Shore University Medical Center (JSUMC)
included a history of exposure to a tick bite. Patients who
did not recall of a tick bite and had some of the following
symptoms: fever, plus or minus rash; malaise, fatigue, joint
pain; anemia, with or without neutrophilia, and decrease
platelet counts were also considered for further testing.
Blood testing was conducted via microscopic examin-
ation of Giemsa-stained smears at JSUMC.
Testing of Patient samples by clinical laboratories
Samples collected by Gedroic Center from Morris County,
and at JSUMC from Ocean and Monmouth Counties of
New Jersey were serially numbered with initials KG and J,
respectively. Aliquots of samples collected at Gedroic
Center were sent to IGeneX reference laboratory for test-
ing by Fluorescence in situ hybridization (FISH) in which
a proprietary fluorescent labeled specific probe is used to
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directly target the 18S rRNA of Babesia species on air
dried blood smear on slides. Samples collected in Ocean
and Monmouth Counties were sent for testing to core la-
boratory at JSUMC. Giemsa-stained thin blood smears
were examined microscopically for the presence of Babe-
sia by the Hematology department of JSUMC and positive
smears confirmed by an attending hematologist.
IFA conducted at NJMS
IFA was conducted for all J samples with four KG samples
included as controls. Slides of Babesia sp. obtained from
Focus Diagnostics were blocked with Phosphate Buffered
Saline (PBS) containing 5% bovine serum albumin (BSA)
and 5% goat serum for 30 min at room temperature and
then probed with 1:128 dilutions of the plasma samples at
37°C for 1h. After three washings with PBS at 5 min inter-
vals, slides were incubated with a mixture of 1:100 dilution
of 4′, 6-diamidino-2-phenylindole (DAPI) to stain parasite
DNA observed by blue fluorescence and anti-human
Alexa 488 conjugated goat antibodies (Molecular Probes,
MA). After 1h incubation at 37°C in dark, slides were
washed three times with PBS at 5 min interval. Cover
glasses were then mounted using 1:1 mixture of glycerol
and PBS and sealed with nail enamel to prevent evapor-
ation and drying. Slides were examined by fluorescent
microscope using oil emersion objective. Green fluores-
cence indicated that patient plasma contains antibodies
against B. microti.
Culture of B. microti and DNA isolation for qPCR
We modified the protocol described previously for in vitro
cultivation of other Babesia species [35] to culture B.
microti. Briefly, human red blood cells (RBCs) (Valley
Biomedical Products, VA) were washed twice with
equal volume of RPMI 1640 by mixing and centrifuga-
tion at 1,000 rpm on bench top centrifuge. In a T75
flask, a mixture of 13 ml RPMI, 4 ml Fetal Bovine
Serum (FBS), 4.5 ml RBCs and ~0.36 mg/ml Gentamicin
was inoculated with 0.2 ml of B. microti Ingram strain cul-
ture stock (ATCC PRA-398), a human babesiosis isolate.
The culture was maintained at 37°C in 5% CO2 incubator
for a few passages only. Giemsa-stained thin smears of
culture were observed and parasitemia determined every
2nd day of culture and approximately half of the culture
medium from the top of the flask was replaced with fresh
medium and RBCs. To determine the sensitivity of detec-
tion by qPCR, total DNA was isolated to prepare standard
curve. Genomic DNA was isolated from pooled B. microti
culture from several passages when parasitemia was >2%.
Briefly, the infected RBC pellet was washed and then lysed
with 2 ml of 0.15% Saponin (Sigma-Aldrich, MO) pre-
pared in PBS by incubation on ice for 30 min. The treated
RBCs were centrifuged at 2900 xg at 4°C for 25 min to
recover parasite pellet. DNA was isolated following
previously described protocol for genomic DNA [36]
and concentation determined. For qPCR, 5μl of each
dilution was used to prepare the standard curve.
B. microti quantitation by qPCR and Patient samples
analyses
Monoplex qPCR was conducted using different dilutions
of genomic DNA isolated from in vitro grown B. microti
using the primers and molecular beacon probe for B.
microti gene encoding Thiamine pyrophosphokinase
(Bmtpk) as we described previously [36]. Briefly, amplifi-
cation was performed in 25 μl reaction mixtures con-
taining AmpliTaq Gold PCR reaction buffer (Life
Technologies, NY) supplemented with 3 mM MgCl2,
500 ng/μl of bovine serum albumin, 250 μM of each
deoxynucleoside triphosphate (dNTP), 500 nM of each
primer, 5 units of AmpliTaq Gold polymerase (Life
Technologies, NY), and 100 nM each of Bmtpk molecu-
lar beacon probe. The amplification program consisted
of initial heating at 95°C for 10 min, followed by 50 cy-
cles of heating at 95°C for 15s, annealing and fluores-
cence detection at 60°C for 30s, and polymerization at
72°C for 20s. Based upon the genome size (6.5 Mb), of
B. microti [37], 8ng of DNA was calculated to contain
106 copies of Bmtpk gene. A standard curve was prepared
from this assay using 5-fold dilutions of B. microti gen-
omic DNA (Fig. 2b). DNA from blood was isolated using
the method described previously in details [36]. Duplex
assays using the conditions as described above were con-
ducted with patient whole blood samples that also contain
leukocytes such that human gene as internal control could
be incorporated in the tests. Primers and molecular bea-
con probe for human actA1 gene were included as in-
ternal control for patient samples in the duplex assays, to
ensure the quality of patient blood DNA was suitable for
PCR [36]. QPCR for each patient sample was conducted
at least three times to confirm results, especially when re-
sults from alternative tests were not available.
Statistical analyses
Statistical analyses were conducted by Rutgers University
Biostatistics and Epidemiology Services Center. Patients
were defined as positive for Babesia infection when IFA/
FISH and/or microscopy results were positive. Otherwise
the babesiosis was considered negative for comparison
with qPCR results. We determined the sensitivity of
qPCR as a measure of the proportion of subjects that
tested positive as compared to the disease state of the
subject based upon clinicians’ determination and accord-
ingly tests were conducted in this study, i.e., Babesia
FISH, IFA and microscopy. Specificity measure in our
study indicated samples negative by qPCR that were
truly negative for babesiosis by criteria described above.
The positive predictive value (PPV) determination
Akoolo et al. BMC Microbiology  (2017) 17:16 Page 3 of 9
indicates that the proportion of subjects that will be
considered positive for Babesia infection given that they
tested positive by qPCR, and the negative predictive
value (NPV) determined the proportion of subjects that
will not have the disease if they tested negative by qPCR.
No previous report based upon qPCR based patient
samples have determined PPV and NPV of their assay
probably due to the lack of a gold standard assay avail-
able for babesiosis.
Results
Study population and babesiosis diagnosis
We examined 192 blood samples collected in 2015 in
Ocean, Monmouth and Morris Counties from patients
ranging in age from 2 to 90 years. Among 106 samples
from Gedroic Center, 78 were asymptomatic and 28
symptomatic. Sixty three samples from JSUMC were con-
sidered asymptomatic and 23 symptomatic. Only blood
sample smears from symptomatic patients stained with
Giemsa stain were examined microscopically (Table 1).
Thus, FISH was only conducted for 37/106 samples from
the Gedroic Center and none of 86 samples from JSUMC.
IFA at NJMS was conducted primarily with JSUMC sam-
ples with four samples from Gedroic Center, 3 FISH nega-
tive and 1 FISH positive included as controls. Only 23
blood samples were examined by microscopy at JSUMC
and 4 from Gedroic Center by CDC. Babesia was detected
in three patients by routine peripheral smear evaluation
without suspicion of a tick bite infection in their differen-
tial diagnosis. Ninety-five patients or approximately 50%
of the patient sample pool represented individuals older
than 40 years (Fig. 1). Forty five (23%) patient samples
from three counties were positive for infection by either
blood smear analysis or FISH. All age groups were affected
with 64% of the babesiosis positive cases older than 40
years (Fig. 1); notably, 13% of younger cases were positive.
Detection of B. microti by qPCR
We compared our qPCR data with the results of samples
tested in the clinical laboratories either by microscopy
(Monmouth and Ocean Counties) or those obtained from
IGeneX using Babesia FISH (Morris County) and also
evaluated untested samples. In our qPCR assays, different
DNA dilutions (Fig. 2a) were used to prepare a standard
curve (Fig. 2b). We conducted monoplex qPCR assay be-
cause erythrocytes rather than whole blood is used for in
vitro culture of B. microti. Based upon the standard curve
and repeat of experiment, we estimated that consistent
sensitivity of detection of our qPCR assay is approxi-
mately 360 copies of the B. microti Thiamine pyropho-
sphokinase (Bmtpk) amplicon.
Concordance of positive babesiosis results with qPCR,
microscopy and IFA testing
Duplex qPCR results in our laboratory with patient sam-
ples that included amplification and detection of gene
encoding Actin A1 as internal control as compared with
the monoplex assay using in vitro culture of B. microti
indicated that parasitemia was often low in patients. We
previously demonstrated that the use of molecular bea-
con probes provides low background, and sensitivity of
detection of Babesia spp., is not affected in our duplex
and even multiplex assays as compared to monoplex test
[36]. Detection of B. microti in samples using our qPCR
demonstrated high correlation with FISH such that of 28
samples positive by FISH, 27 (96%) were positive by
qPCR. There was less concordance between FISH nega-
tive and qPCR results such that 72% (13/18) of FISH
negative samples were also negative by qPCR (Additional
file 1: Table S1). Due to blood samples storage for a
week at 4°C prior to making smears, blood smears were
difficult to confirm for Babesia presence at NJMS.
Therefore, three blood sample (from Gedroic Center)
smears that looked potentially positive and one clearly
negative were sent to CDC for evaluation. Smear quality
affected confirmatory determination at CDC too and
were considered negative for this analysis.
We used qPCR results for patient samples as positive
if the cycle number could be plotted on the standard
curve in Fig. 2. Our qPCR results also showed significant
Table 1 Analysis of qPCR, conducted in a blinded manner to detect the presence of B. microti DNA and comparison with Babesia
FISH, IFA and microscopic examination of Giemsa-stained thin blood smear
qPCR Results from 3
repeats (No. of Samples)#
IFA Babesia FISH Microscopy of Giemsa-Stained blood smear
Positive Negative NT Positive Negative NT Positive/± Negative NT
+/+/+ (3) 0 0 3 2 0 1 1 0 2
+/+/- (65) 7/1± 19 38 7 5 53 8/1 ± a 4 52
+/-/- (24) 0 2 22 9 0 15 7 0 17
-/-/- (100) 1 40 59 1 13 86 0 7 93
#Each plus or minus sign indicates the results from one qPCR assay. Patient samples were considered positive or negative by qPCR based upon comparison with
the standard curve in Fig. 2b
aMicroscopic examination of Giemsa-stained blood smears provided uncertain results for Babesia presence. IFA ± indicates only some of the parasites
showed fluorescence
NT-Not Tested. NT samples were considered negative for diagnosis of babesiosis by physicians based upon symptomatology and also for statistical analyses in
this study
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(96%) agreement with microscopy data obtained at
JSUMC such that of seven samples confirmed negative
by microscopy, only one was positive by qPCR (Table 1,
and Additional file 1: Table S1). Seven of sixteen micro-
scopically positive samples (at JSUMC) tested positive by
qPCR only once, most likely due to stochastic detection
in patient blood samples with low parasitemia. Of the
sixty-two samples that were not tested for Babesia at
JSUMC, twenty-four samples (39%) were positive by
qPCR at least twice. Among these twenty-four samples,
eight were also positive by IFA (Table 1, Additional file 1:
Table S1 and Fig. 3). Of 29 qPCR positive samples tested
by IFA, 21 were IFA negative and looked similar to the
negative controls (Additional file 1: Table S1), suggesting
that plasma of these patients did not yet possess
antibodies against Babesia antigens. In any case, we were
able to verify our qPCR results for some samples by IFA.
A practical “Gold standard” test is not available for de-
tection of Babesia infection at present, and highlights the
need for better methods of detection. In this study, we de-
fined babesiosis based-upon the results of the microscopy,
FISH and/or IFA such that a positive result for each of
these tests was considered a positive disease state, other-
wise it was considered as negative for babesiosis (Table 2).
We also summarized results presented in Table 1 for stat-
istical analysis in Table 3. Based on these assignments,
there were 53 positive disease states and 139 negative
babesiosis cases among 192 patients.
Data Analyses from Table 3
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PPV ¼ # of True Positives
# of Positive Calls
¼ 51
92
¼ 0:554 ¼ 55:4%
Fig. 2 Determine the sensitivity of detection of B. microti using in vitro grown parasites by qPCR. a Amplification plots of Bmtpk gene in monoplex
qPCR assay starting with 106 gene copies (8ng DNA). Five-fold dilutions of genomic DNA of B. microti purified from in vitro grown culture using Bmtpk
primers and molecular beacon probe were used to determine quantities of B. microti. Dotted line indicates ‘no template’ control. b A high coefficient
of correlation (r2 = 0.9822) between the amplification cycle number (Ct values) and Bmtpk copy number representing the parasite numbers obtained
from the standard curve indicates that qPCR can be used effectively to evaluate even low level of parasitemia in patients
Fig. 1 B. microti infection relationship with the age of patients.
Whole blood samples obtained from 192 patients from Morris,
Ocean and Monmouth Counties of New Jersey examined by FISH or
microscopic examination of Giemsa-stained thin smears indicates a
higher babesiosis incidence in patients older than 40 years of age
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NPV ¼ # of True Negatives
# of Negative Calls
¼ 98
100
¼ 0:980 ¼ 98:0%
Standard Error of NPV ¼
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¼ 0:014 ¼ 1:4%
All 95% confidence intervals were calculated as:
Confidence Interval ¼ Point Estimate  1:96
 Standard Error
Fig. 3 Detection of B. microti presence in the qPCR positive patient samples by IFA (Top Panels) Two representative samples (J22 and J67) from
Ocean and Monmouth Counties not tested for Babesia by microscopy at JSUMC show green fluorescence due to reactivity of antibodies in
patient plasma with the parasites followed by detection with Alexa 488 conjugated secondary antibodies, when observed by using FITC filter
indicating positive IFA results (marked by arrows). (Bottom Panels) Blue fluorescence due to DAPI staining shows the parasites present (marked by
arrows) in each field of view of the Nikon 80i fluorescence microscope at × 1000 magnification when Apo-Plan TIRF objective was used. Scales
shown represent respective panels of Giemsa-stained microscopy and IFA
Table 2 Defining babesiosis disease state based upon Babesia FISH, IFA and microscopic examination of Giemsa–stained patient
blood smears
Giemsa-staining and Microscopy
Positive Negative Not tested/Indefinite Total
FISH/IFA Positive 0 1 36 37a (19.3%)
Negative 0 7 128 135 (70.3%)
Not tested 16 4 0 20 (10.4%)
Total 16a (8.3%) 12 (6.3%) 164 (85.4%) 192
aIndicates the assignment of positive babesiosis state
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By analysis of the qPCR results as compared with the
babesiosis disease state as calculated above, the sensitiv-
ity of qPCR was determined to be 96.2% with a 95% con-
fidence interval of 91.1 to 100% (Table 4). The specificity
of qPCR was 70.5% with a 95% confidence interval of
62.9 to 78.1%. The PPV of qPCR was 55.4% (51/92) with
a 95% confidence interval of 45.3–65.6% and the NPV
was found to be 98.0% (98/100) with a 95% confidence
interval of 95.3–100% (Table 4).
Discussion
We report here testing for Babesia spp. in 192 patient
blood samples using our qPCR assay [36] and compared
the results with those obtained by microscopic examin-
ation of Giemsa-stained blood smears, Babesia FISH or
by serology. A significant association of babesiosis with
patients’ older age (>40 years) in New Jersey here is simi-
lar to the pattern reported by CDC based upon 1,762
babesiosis cases from twenty seven states in the USA in
2013. A higher percentage of younger patients, 13% in our
sample set versus approximately 3% cases by CDC, indi-
cated that in New Jersey babesiosis affects a broader age
range of individuals and is not just a phenomenon of older
age. Thus, babesiosis is a public health concern for all
populations.
Groups of patients who were asymptomatic, exhibited
non-specific symptoms, or lacked spectrum of symptoms
considered by physicians to suspect Babesia infection
were not tested by clinical laboratories, such that only
12% of patient samples were examined microscopically
in this study. Recently, PCR/qPCR assays have been de-
veloped by some laboratories to detect the presence of
Babesia species [25, 34, 36, 38–41]. These tests were
found to be more sensitive than microscopic examination
particularly when parasitemia is low. In our study, we
found 96% agreement between our qPCR test results with
those obtained by microscopic examination at JSUMC or
with FISH, demonstrating the accuracy of the qPCR assay.
Furthermore, 100% concordance of our qPCR among
microscopically positive samples (Table 1) demonstrates
the accuracy of our qPCR. Even though qPCR provides a
better approximation of parasitemia and will be very use-
ful before treatment, clinicians should consider the caveat
that DNA of pathogens often persists at least for a limited
time after completion of treatment regimen as was re-
cently reported using a qPCR method involving 18S
rRNA gene amplicon and respective primers and probe
[41]. Ultimately nucleic acids are degraded by nucleases
present in plasma. In addition, twenty-four of sixty-two
(39%) samples not tested for babesiosis at the clinic also
showed positive results with our qPCR assay, validating
the importance of this method as a diagnostic assay for
field application. These results further emphasize the
success of our test in detection of Babesia infection in
patients at different stages of infection.
In total, 71% qPCR positive samples from all three
counties were positive for babesiosis by IFA. Serological
tests are indirect tests that measure the host response to
an infection and are not reliable indicators of active in-
fection. High sensitivity of qPCR (96.4%) indicates that
serological tests or microscopic examination of smears
after Giemsa staining and FISH are useful for positive
outcome before treatment; however, negative results by
these tests do not necessarily indicate the absence of in-
fection by Babesia species. In the absence of an efficient
gold standard diagnostic assay, negative serological results
during early stage of disease or by negative microscopic
observation due to low parasitemia could be responsible
for lower specificity (70.5%) of our qPCR for babesiosis.
To verify our results, qPCR was conducted at least three
times for each sample (Table 1). Data from at least one
alternative test was generated for all patient samples.
Table 3 Summary table of qPCR results comparison with the serological tests and microscopy used for statistical analyses, and PPV
and NPV determinations
Babesiosis Disease Present Babesiosis Disease Absent Total
Positive qPCR 51 41 92 (47.9%)
Negative qPCR 2 98 100 (52.1%)
Total 53 (27.6%) 139 (72.4%) 192
Table 4 Metrics of qPCR efficacy compared to the positive or negative babesiosis disease state as determined by IFA and
microscopy
qPCR Metrics Point Estimate 95% Confidence Interval (Lower Bound, Upper Bound)* Standard Error
Sensitivity 96.2% (91.1%, 100.0%) 2.6%
Specificity 70.5% (62.9%, 78.1%) 3.9%
Positive Predictive Value 55.4% (45.3%, 65.6%) 5.2%
Negative Predictive Value 98.0% (95.3%, 100.0%) 1.4%
*Confidence intervals with upper bounds >100% are shown as 100%
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Samples that tested positive only once by qPCR likely
indicate stochastic detection of Babesia when parasitemia
is low. To support these qPCR results, we also tested sam-
ples by IFA. In fact, among16 samples positive once by
qPCR, 9 were also found to be positive on microscopic
examination, validating our qPCR assay. Detection of
Babesia by qPCR in 22/78 negative/untested samples
(28%) at Gedroic Center may represent acute disease.
However, we cannot rule out the possibility of false-
positive result when qPCR is positive only 1/3 times it
is tested and when results from an alternative test are
not available. A high NPV (98.0%) determination for
qPCR indicates that the negative qPCR results have a
very high level of agreement with a negative disease.
Relatively lower PPV (58.7%) could be attributed to de-
tection of the early babesiosis in patients by our sensi-
tive molecular beacon probe-based qPCR assay when
parasitemia is very low making microscopy difficult and
because adaptive immune response has not yet estab-
lished in patients. Thus, positive qPCR individuals do
not show positive disease state by FISH/IFA tests or by
microscopic examination of Giemsa-stained blood smears.
Supporting this premise, patient samples in our study
often showed parasitemia at the lower end of detection by
qPCR as determined by comparison with data obtained
from in vitro grown B. microti (Fig. 2).
Overall, we found that our qPCR assay is more sensi-
tive, reliable and fast method for detection of Babesia
infection. Our qPCR results together with those from
complementary tests presented here suggest that inci-
dence of babesiosis has increased significantly from less
than 50 reported cases in New Jersey state in 2001 to
92 case in 2015 just in 3/21 NJ counties. This could be
partially attributed to increased awareness and testing
of patients for babesiosis. Since our samples may be a
representation of the pattern observed in other endemic
regions, testing of patient samples in triplicate by qPCR
with at least two positive results will provide rapid, effi-
cient and sensitive diagnostic of babesiosis and will facili-
tate design of proper treatment regimens. This method
could also be widely implemented for screening of blood
donors, and for testing donated blood and blood compo-
nents in order to reduce the risk of TTB.
Conclusions
Results of our novel qPCR assay with patient blood sam-
ples for babesiosis were compared with those obtained
by FISH, IFA and microscopy. A combined positive rate
of 47% indicates a high occurrence of babesiosis in three
counties of New Jersey. Furthermore, this study confirms
that currently used tests do not reliably detect early
acute babesiosis especially when parasitemia is low and
patients are asymptomatic. Diagnostic tests, such as time
consuming and labor intensive microscopic examination
of thin blood smears or Babesia FISH, are often not car-
ried out when disease symptoms are not clear. These
tests are particularly not feasible for large scale screening
purposes and cannot be automated. Therefore, the cur-
rently used tests together result in underestimation of
the incidence of babesiosis, as has also been reported for
Lyme disease in the endemic regions of tick-borne dis-
eases. Our qPCR assay using molecular-beacon probes is
highly sensitive, and showed significant specificity, PPV
and NPV for detection of B. microti presence in patients’
blood and could become an efficient stand-alone diagnos-
tic test, particularly for blood screening, or when com-
bined with IFA and/or microscopy.
Additional file
Additional file 1: A novel quantitative PCR detects Babesia infection in
patients not identified by currently available non-nucleic acid amplification
tests. Table S1. Analyses of patient blood samples tested by qPCR, FISH, IFA
and microscopic examination of Giemsa-stained blood smears. (DOCX 17 kb)
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